IDENTIFICATION, OPTIMIZATION AND USE OF CRYPTIC HLA-A24 EPITOPES FOR IMMUNOTHERAPY

• 收藏
• 分享

专利权人:

VAXON BIOTECH

发明人:

KOSTANTINOS (KOSTAS) KOSMATOPOULOS,JEANNE MENEZ-JAMET

申请号：

PT09785926

公开号：

PT2413956T

申请日:

2009.04.02

申请国别(地区):

PT

年份:

2016

代理人:

摘要：

The present invention discloses peptides such as an isolated peptide consisting of an immunogenic HLA-A*2402-restricted epitope. For example, the isolated peptide may be selected from the group consisting of KYGVLLKTL (SEQ ID NO:11) RYMRQFVAL (SEQ ID NO: 12) RYVSRLLGI (SEQ ID NO: 13) RYGKGWDLL (SEQ ID NO: 14) RYLVQVQAL (SEQ ID NO: 15) and RYWELSNHL (SEQ ID NO: 16).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/